Cancer
Study shows female 'advantage' in melanoma survival
Women are less likely than men to die from skin cancer, according to a study in the Journal of Clinical Oncology. Even after adjusting for earlier diagnosis in women, the female survival advantage persisted.
The scientists looked closely at four treatment trials for melanoma, the most dangerous form of skin cancer. They found that women were 30% less likely to die overall from their melanoma. Of the estimated 8,790 deaths related to melanoma in 2011 in the United States, 35% were in women.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.